Rare diseases
Investigational molecules
Locations
Robert-Roessle-Strasse 10-79, Buch, 13125 Berlin, Germany
Ariceum Therapeutics GmbH focuses on somatostatin receptor positive neuroendocrine tumours, with clinical interest centred on disease populations defined by receptor expression and long-term treatment follow-up.
The sponsor’s research activity in this area is directed toward clinical monitoring of patients with neuroendocrine tumours, reflecting involvement in specialised oncology settings.
Ariceum Therapeutics GmbH runs clinical trials in conditions such as Neuroendocrine tumour, among others.
Clinical trials registered by this sponsor – none is enrolling right now.
FranceIncrease visibility for your trials and help patients find your site through our platform.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
